The potential of modelling

R. Bordas (Oxford, United Kingdom)

Source: International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?
Session: AirPROM: can imaging and modelling take us beyond FEV1?
Session type: Session
Number: 2846

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Bordas (Oxford, United Kingdom). The potential of modelling. International Congress 2014 – AirPROM: can imaging and modelling take us beyond FEV1?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The need and potential of patient-specific modelling
Source: Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Year: 2012



Leveraging causal modeling to predict future COPD
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Which modelling methodology is best?
Source: ERS Research Seminar 2017 – The impact of air pollution on respiratory health
Year: 2018


The evaluation of frequency dependence of resistance using a patient-specific 3D physical model and a computational model
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017

The optimal study design for identifying gene-environment interaction effects in large-scale studies
Source: International Congress 2018 – Gene-environment interactions in the omics era
Year: 2018


Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017



Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006

Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020
Year: 2020



Modelling the lung from two-dimensional to multi-scale approaches
Source: Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Year: 2012

Modelling respiratory mechanics: a multi-scale approach
Source: International Congress 2015 – PG7 Basic respiratory mechanics
Year: 2015




Asthma-COPD overlap: current understanding and the utility of experimental models
Source: Eur Respir Rev, 30 (159) 190185; 10.1183/16000617.0185-2019
Year: 2021



Unbiased approaches to asthma stratification: the road to novel therapies
Source: International Congress 2017 – PG15 Asthma stratification
Year: 2017


Applying new respiratory function technologies to the elderly and the potential of future lung regeneration
Source: Virtual Congress 2020 – Lung health and respiratory function at all ages
Year: 2020


How can the data derived Bayesian network model help for screening of respiratory diseases?
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019


Unbiased approaches to asthma stratification - the road to novel therapies
Source: International Congress 2018 – PG17 Asthma phenotyping
Year: 2018


Using joint modelling to assess the association between a time-varying biomarker and a survival outcome: an illustrative example in respiratory medicine
Source: Eur Respir J, 57 (2) 2003206; 10.1183/13993003.03206-2020
Year: 2021



Some current challenges in statistical methods to illuminate disease genetics
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008